99 related articles for article (PubMed ID: 10049831)
1. Smubp-2 represses the Epstein-Barr virus lytic switch promoter.
Zhang Q; Wang YC; Montalvo EA
Virology; 1999 Mar; 255(1):160-70. PubMed ID: 10049831
[TBL] [Abstract][Full Text] [Related]
2. Binding of the ubiquitous cellular transcription factors Sp1 and Sp3 to the ZI domains in the Epstein-Barr virus lytic switch BZLF1 gene promoter.
Liu S; Borras AM; Liu P; Suske G; Speck SH
Virology; 1997 Feb; 228(1):11-8. PubMed ID: 9024805
[TBL] [Abstract][Full Text] [Related]
3. Characterization of proteins binding to the ZII element in the Epstein-Barr virus BZLF1 promoter: transactivation by ATF1.
Wang YC; Huang JM; Montalvo EA
Virology; 1997 Jan; 227(2):323-30. PubMed ID: 9018131
[TBL] [Abstract][Full Text] [Related]
4. An alternative pathway for transcription initiation involving TFII-I.
Roy AL; Malik S; Meisterernst M; Roeder RG
Nature; 1993 Sep; 365(6444):355-9. PubMed ID: 8377828
[TBL] [Abstract][Full Text] [Related]
5. Developmental specificity of recruitment of TBP to the TATA box of the human gamma-globin gene.
Duan ZJ; Fang X; Rohde A; Han H; Stamatoyannopoulos G; Li Q
Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5509-14. PubMed ID: 11960008
[TBL] [Abstract][Full Text] [Related]
6. Carboxy-terminally truncated form of a coactivator UTF1 stimulates transcription from a variety of gene promoters through the TATA Box.
Fukushima A; Nishimoto M; Okuda A; Muramatsu M
Biochem Biophys Res Commun; 1999 May; 258(3):519-23. PubMed ID: 10329418
[TBL] [Abstract][Full Text] [Related]
7. Localization of the 12-O-tetradecanoylphorbol-13-acetate response of the human ornithine decarboxylase promoter to the TATA box.
Reddig PJ; Kim YJ; Verma AK
Mol Carcinog; 1996 Oct; 17(2):92-104. PubMed ID: 8890958
[TBL] [Abstract][Full Text] [Related]
8. Regulation of KLF5 involves the Sp1 transcription factor in human epithelial cells.
Chen C; Zhou Y; Zhou Z; Sun X; Otto KB; Uht RM; Dong JT
Gene; 2004 Apr; 330():133-42. PubMed ID: 15087132
[TBL] [Abstract][Full Text] [Related]
9. Wild-type but not mutant p53 can repress transcription initiation in vitro by interfering with the binding of basal transcription factors to the TATA motif.
Ragimov N; Krauskopf A; Navot N; Rotter V; Oren M; Aloni Y
Oncogene; 1993 May; 8(5):1183-93. PubMed ID: 8479742
[TBL] [Abstract][Full Text] [Related]
10. Competition with TATA box-binding protein for binding to the TATA box implicated in human cytomegalovirus IE2-mediated transcriptional repression of cellular promoters.
Wang YC; Huang CF; Tung SF; Lin YS
DNA Cell Biol; 2000 Oct; 19(10):613-9. PubMed ID: 11058964
[TBL] [Abstract][Full Text] [Related]
11. Requirement for transcription factor IIA (TFIIA)-TFIID recruitment by an activator depends on promoter structure and template competition.
Lieberman PM; Ozer J; Gürsel DB
Mol Cell Biol; 1997 Nov; 17(11):6624-32. PubMed ID: 9343426
[TBL] [Abstract][Full Text] [Related]
12. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
[TBL] [Abstract][Full Text] [Related]
13. Identification of a novel element involved in regulation of the lytic switch BZLF1 gene promoter of Epstein-Barr virus.
Kraus RJ; Mirocha SJ; Stephany HM; Puchalski JR; Mertz JE
J Virol; 2001 Jan; 75(2):867-77. PubMed ID: 11134300
[TBL] [Abstract][Full Text] [Related]
14. Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta.
Bowser BS; Morris S; Song MJ; Sun R; Damania B
Virology; 2006 May; 348(2):309-27. PubMed ID: 16546233
[TBL] [Abstract][Full Text] [Related]
15. DNA sequence-specific recognition by the Saccharomyces cerevisiae "TATA" binding protein: promoter-dependent differences in the thermodynamics and kinetics of binding.
Petri V; Hsieh M; Jamison E; Brenowitz M
Biochemistry; 1998 Nov; 37(45):15842-9. PubMed ID: 9843390
[TBL] [Abstract][Full Text] [Related]
16. TFIIA changes the conformation of the DNA in TBP/TATA complexes and increases their kinetic stability.
Hieb AR; Halsey WA; Betterton MD; Perkins TT; Kugel JF; Goodrich JA
J Mol Biol; 2007 Sep; 372(3):619-32. PubMed ID: 17681538
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of TBP binding by activators and general transcription factors.
Li XY; Virbasius A; Zhu X; Green MR
Nature; 1999 Jun; 399(6736):605-9. PubMed ID: 10376604
[TBL] [Abstract][Full Text] [Related]
18. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
[TBL] [Abstract][Full Text] [Related]
19. Transcription factor IIA derepresses TATA-binding protein (TBP)-associated factor inhibition of TBP-DNA binding.
Ozer J; Mitsouras K; Zerby D; Carey M; Lieberman PM
J Biol Chem; 1998 Jun; 273(23):14293-300. PubMed ID: 9603936
[TBL] [Abstract][Full Text] [Related]
20. Recruitment of TBP or TFIIB to a promoter proximal position leads to stimulation of RNA polymerase II transcription without activator proteins both in vivo and in vitro.
Huh JR; Park JM; Kim M; Carlson BA; Hatfield DL; Lee BJ
Biochem Biophys Res Commun; 1999 Mar; 256(1):45-51. PubMed ID: 10066420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
